Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder-Reference-Cited by-同舟云学术

Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder

Published:2021-04-01 Issue:3 Volume:31 Page:179-186
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

López Frank A.¹,Faraone Stephen V.²,Newcorn Jeffrey H.³,Doll Helen A.⁴,Rhoten Stephanie⁵⁶,Lewis Hannah B.⁷,Khan Tayyaba F.⁸,DeSousa Norberto J.⁹,Sallee Floyd R.¹⁰,Incledon Bev⁹,

Affiliation:

1. Pediatric Neurology, P.A., Winter Park, Florida, USA.

2. Departments of Psychiatry and of Neuroscience and Physiology, State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA.

3. Mount Sinai Medical Center, New York, New York, USA.

4. Clinical Outcomes Assessments, ICON plc, Oxford, United Kingdom.

5. Patient Centered Outcomes, ICON plc, South San Francisco, California, USA.

6. Current address: IQVIA, San Francisco, California, USA.

7. Patient Centred Outcomes, ICON plc, London, United Kingdom.

8. Highland Therapeutics, Inc., Toronto, Canada.

9. Ironshore Pharmaceuticals & Development, Inc., Camana Bay, Grand Cayman, Cayman Islands.

10. Ironshore Pharmaceuticals, Inc., Durham, North Carolina, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health